Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TSM vs MRNA✓SelectedUSD · MRNATSM vs MRNA performance historyLatest closeAs of-3.68%11/17
Stock and ETF performance explorer

TSM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+227.3%
MRNA return
-11.9%
Excess return
+239.2%
Maximum drawdown
-56.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.7%-3.9%+0.3%-3.5%
7D-9.3%-17.6%+8.3%-8.3%
30D-12.8%-5.1%-7.7%-12.6%
3M-16.3%+220.8%-237.1%-24.9%
6M-10.6%+321.7%-332.3%-23.4%
YTD+19.3%+601.3%-582.0%-5.9%
1Y+28.9%+735.2%-706.3%-1.2%
3Y+275.9%+170.5%+105.4%+218.2%
5Y+227.3%-14.6%+241.9%+190.7%
All+227.3%-11.9%+239.2%+190.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling